Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity(TM) Acute Infection and Sepsis Test System
Regulatory Milestone Designed to Expedite Path to FDA Clearance and CMS Coverage
SUNNYVALE, Calif., Nov. 28, 2023 -- (Healthcare Sales & Marketing Network) -- Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the US Fo... Diagnostics, FDA Inflammatix, TriVerity Test System, Myrna Instrument, Sepsis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Marketing | Pharmaceuticals